The governance of effective regulatory co-operation

Given the range and complexity of regulation – nationally, internationally, and regionally – and given the limited time available for the development of this paper, the analysis that follows must be viewed as very selective and exploratory in nature.2 The paper provides only a descriptive summary account of each of the nine case study co-operative agreements examined. [...] The European Medicines Contribute to the protection - Centres on the EMEA’s - Priorities established Evaluation Agency and promotion of public and management of two routes through the hierarchical animal health by: for the authorization of structure of the EMEA and - mobilizing scientific medicinal products, namely its various committees. [...] The US-South Korea Arrangement on the Prevention of Major Chemical Accidents The first example of comparative international regulatory co-operation is the Memorandum of Cooperation Concerning the Prevention of Major Chemical Accidents, signed and agreed to in 2003 by the United States Chemical and Hazard Investigation Board (CSB) and the Korean Occupational Safety and Health Agency (KOSHA) two age [...] If the CSB is able to respond positively, the details of the assistance and the form the assistance will take should be worked out on a case-by-case basis by the heads of each agency or their designee. [...] The Australia-New Zealand Agreement for the Establishment of a Joint Scheme for the Regulation of Therapeutic Products Established in 2003, this Agreement’s objective is “to safeguard public health and safety in Australia and New Zealand by establishing and maintaining a joint scheme consistent with international best practice for the regulation of the quality, safety, and efficacy or performance